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Abstract
Meningococcal disease in Ukraine represents an important cause of mortality mostly 
among the child population of less than five-year old. The present study illustrates the 
advancement on understanding of Meningococcal epidemiology across the national level 
by using20 years of data provided by the Ministry of Health of Ukraine on a constant sur-
vey of the disease. This unique set of data includes: demography (census); disease inci-
dence from 1973 to 2015 (i.e., purulent meningitis etiologic diagnostic); Meningococcal 
disease mortality; anonymized demographic data (sex, age, leaving area/city/village); 
Comparative etiology of purulent meningitis; serogroups of invasive meningococcal dis-
ease; carriers prevalence; a set of clinical data (meningitis, meningococcemia, nasophar-
yngitis, etc.); and a set of environmental data (season, etc.). The dynamic of the disease 
is described for over the past 20-year period of time including incidence, prevalence, 
spatial distribution, seasonality, and risk factors. Existing state of the art of meningo-
coccal infection epidemiology is presented for the all country. Ultimately, time series 
analysis of record and spatial distribution over such a long period of time supported the 
development of original construct of various models encompassing risk and vulnerabil-
ity, and ways to improve epidemiological surveillance, and develop vaccination strate-
gies in country.
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1. Introduction
1.1. Background
To date, purulent bacterial meningitis (PBM) remains a global health challenge. Meningococcal 
meningitis occurs in small clusters throughout the World with seasonal variation, accounts 
for a variable proportion of epidemic bacterial meningitis, and is one of the leading causes of 
such meningitis globally with a burden that, in 2012 encompassed 395,230 deaths, or 0.7% of 
global mortality [1, 2].
Meningococcal disease or meningococcal meningitis is caused by bacterium Neisseria menin-
gitidis, also called meningococcus. Meningococcal bacteria may cause infection, which occurs 
in different compartment of the body, called invasive meningococcal disease (IMD), including 
skin, gastrointestinal tract, or respiratory tract, among others. Ultimately, the bacteria may 
pass through the bloodstream and reach the nervous system causing meningococcal meningi-
tis. After an incubation period of 2–10 days, clinical presentation starts with symptoms similar 
to influenza (flu-like), which cause nausea, vomiting, rash, increased sensitivity to light, and 
confusion. Symptoms of meningococcal disease appear usually as a sudden onset of fever, 
headache, and stiff neck. When treated, most patients with meningococcal meningitis recover 
completely with appropriate antibiotic therapy and rapid medical attention. Also, meningitis 
can cause severe brain damage and be fatal for 50% of untreated cases.
There is no animal reservoir, and N. meningitidis is obligate commensals of human and can 
colonize the nasopharyngeal mucosa without affecting the host, a phenomenon known as 
carriage. Such asymptomatic carriage of meningococcus is the most prevalent form of menin-
gococcal infection. In none-epidemic settings, approximately 10–35% of healthy individuals 
carry N. meningitidis in the upper airway [3, 4]. Thus, only in very rare cases, N. meningitidis 
is the cause of invasive meningococcal disease. N. meningitidis is transmitted from person-to-
person through respiratory droplets or throat secretions from carriers or eventually patients. 
The risk of transmission and spread increases in particular by close and prolonged contact 
(e.g., kissing, sneezing, coughing, promiscuity, and sharing food or drinking utensils) with an 
infected person (symptomatic or asymptomatic (i.e., carrier). Moreover, such risk increases 
with recent upper respiratory infection, while young children and teen-agers are at greatest 
risk of infection.
Several types of meningococcal vaccines are available including Meningococcal Polysaccharide 
vaccines as bivalent (groups A and C), trivalent (groups A, C and W), or tetravalent (groups A, 
C, Y and W). Tetravalent A, C, Y, and W conjugate vaccines have been licensed since 2005 for 
use in children and adults in Canada, the United States of America, and Europe. Since 1999, 
meningococcal conjugate vaccines against group C have been available and widely used. 
(e.g., Meningococcal conjugate vaccine; Meningococcal polysaccharide vaccine; Serogroup B 
Meningococcal B) and are recommended vaccines as the best that can prevent meningitis 
infection. As of June 2015, over 220 million persons aged 1–29-year old received meningococ-
cal A conjugate vaccine against the most meningitis type prevalent among 15 countries of the 
African belt [2].
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1.2. Epidemic pattern of Meningococcal meningitis in Europe
There is a reported reduction of morbidity of Invasive Meningococcal Disease (IMD) in the 
European countries (i.e., EU/EEA): The total number of confirmed cases of the IMD fell from 
7995 to 3463 for the period from 1999 to 2012. In countries with a meningococcal serogroup C 
vaccination program, the number of cases fell from 4840 to 2380, in countries where system-
atic immunization campaigns are not applied incidence decreased from 3155 cases to 1083 
cases [5, 6]. Therefore, a reduction of IMD mortality in EU/EEA countries was reported that 
diminished from 0.163 to 0.055 per 100,000 people from 1992 to 2012 [7]. Although, IMD is 
relatively rare in Europe (0.68 cases/100,000 people in 2012), country-specific rates of con-
firmed IMD range from 0.11 to 1.77 cases per 100,000 people [8].
Worldwide, most IMD cases are caused by serogroups B and C. Serogroup Y prevalence has 
been increasing but remains less frequent than B and C. An overall decreasing trend has been 
observed over the last 10 years, partly attributable to the introduction of serogroup C conju-
gate vaccine to national immunization schedules in several European countries.
Finally, it is of importance to strengthen surveillance of meningococcal disease in order to 
reduce burden of the disease (including patient and carrier) and to evaluate the impact of the 
ongoing vaccination programs, and support decision-makers with respect to the availability 
of new vaccines [6].
2. Meningococcal infection biosurveillance and Public Health response 
and control in Ukraine
The purpose of epidemiological surveillance of meningococcal infection (MI) is to prevent 
deaths and reduce disease morbidity risk groups. A retrospective epidemiological analysis 
of MI must include data monitoring morbidity risk groups (e.g., children aged of 0–1 and 
1–4 years old), and other young people as which came as socio-organized as group indica-
tors (i.e., including school, kindergartens, orphanages, vocational colleges, university, among 
others). Equally important is the analysis of total mortality and mortality by risk groups and 
their dynamics. In addition, data are analyzed from microbiological monitoring of “indicator 
groups.” Moreover, there is a national serological monitoring of MI pathogens.
In epidemic foci of MI, patients with IMD are hospitalized and isolated while and a 10 days’ 
medical observation of contact-persons is conducted (thermometry and examination of the 
skin and mucous membranes of the nasopharynx). Bacteriological tests are done twice among 
organized groups and once at home (i.e., family contact) within epidemic foci. Surveillance of 
other purulent meningitis is carried out as for meningococcal infection.
In Ukraine, since the 1920s, MI cases introduced are registered as well as Haemophilus influenzae 
type B Hib-meningitis cases are registered since 2010. From 2012, pneumococcal meningitis 
(PM) and all other bacterial meningitis are also registered. Vaccination against Hib-infection 
was included in the routine immunization program in 2006 by the Ministry of Health, while it 
is considering now to introduce a national vaccination campaigns against meningococcal and 
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pneumococcal disease. As of 2013, an estimated of 68.9% of Ukrainians lives in urban areas 
including the 68.2% of the population over 45 years old [8].
Since 2007, there is a Central Reference Laboratory for invasive bacterial diseases (IBD) char-
acterizing and supervising the dynamic of IBD pathogens in order to forecast and reduce 
(preventive measures) the incidence of IBD. The State institution “Ukrainian Centre for 
Disease Control and monitoring of the Ministry of Health of Ukraine” is a reference as part of 
the IBD-laboratory WHO and UNICEF networks. A sentinel surveillance system included all 
patients younger than 5 years clinically suspected of meningitis and hospitalized as hospital 
in-patient of either the department of infectious disease or intensive care unit.
3. Temporal and spatialdynamics of meningococcal infection in Ukraine
3.1. Place and time of meningococcal infection and other purulent meningitis
Purulent bacterial meningitis (PBM) is a group of diseases of multi-bacterial etiology that deter-
mines the nature of the treatment, laboratory diagnostic approach and epidemiological charac-
teristics for control and prevention. Indeed, PBM transmission and clinical presentation are fully 
dependent on the etiologic agent and concurrent risk factor. PBM etiology will ensure a success-
ful causal treatment and important information regarding the whole nosology of the meningitis 
and epidemiology pattern. Bacteriological etiological diagnosis of PBM has been carried out for 
24 years (1992–2015) in Ukraine (Ukrainian Centre for Disease Control and monitoring of the 
Ministry of Health): 37,843 cases were registered as PBM, among them, 18,878 were of purulent 
meningitis of meningococcal origin and other IMD. The ratio of meningococcal meningitis to 
non-meningococcal meningitis was about more or less of 1:1 (i.e., 49.89 to 50.11%) (Figure 1).
Figure 1. Incidence dynamics of different etiological forms of bacterial meningitis (Ukraine, 1992–2015). Legend: 
Abscissa = time (year); Ordinate = case of bacterial meningitis per 100,000 people; Empty diamond = Meningococcal 
Disease (MD); Empty square = Other Meningitis (caused by Staphylococcus aureus, Streptococcus groups A and B, Klebsiella 
pneumoniae, Escherichia coli, Listeria monocytogenes and PBM of unknown etiology); Empty circle = PBM pneumococcus 
(Purulent Bacterial Meningitis caused by Streptococcus pneumonia); Cross = Haemophilus influenzae type b (Hib).
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The use of microbiological monitoring of PBM in Ukraine allowed to determine the etio-
logical origin of 37,843 cases from 1992 to 2012. The basic etiological agents PBM included: 
Meningococci (49.89%); Pneumococci (6.34%); Staphylococci, Streptococci and others 
(Escherichia spp., Listeria spp., etc.) (17.30%); Hib-infection (0.71%), and pathogens of unknown 
etiology (25.77%). Among the 21,359 registered cases of MI, 9986 cases (46.75%) were con-
firmed to be of bacteriological origin. Bacteriological confirmation of MI ranges from 33.71% 
in 1993 to 55.95% 9 years after (2002) (Figure 2).
Meningococcal infection predominated among all bacterial meningitis during the whole 
period of observation. However, half of all non-meningococcal meningitis as well as IMD did 
not have bacteriological confirmation the bacteriological tests were done almost in all patients 
but were not positive for half of all meningococcal meningitis. Thus, the total sensitivity of 
bacteriological tests was inadequate (nearly 50%).
3.2. Time series of morbidity and mortality of meningococcal infection in Ukraine
In 1969, an incidence of less than 0.9 per 100,000 people of MI was recorded. Since then, the 
incidence began to rise and lasted until 1985. For decade (1973–2012), MI incidence (includ-
ing all clinical forms) ranged from 6.7 (1985) to 0.83 (2012) per 100,000 people. Instead, in the 
long term, of IMD and mortality appear be very specific and different dynamics, while IMD 
incidence is much lower and ranges from 2.22 (1974) to 0.75 (2012) per 100,000 people with a 
mortality from 0.84 (1983) to 0.09 (Figure 3).
There is a significant decrease morbidity and mortality of MI for the last 33 years in Ukraine. 
Between 1983 and 2015 the incidence of MI decreased by 7.2 times. Between 1973 and 2015 
Figure 2. Etiological structure of purulent meningitis cases in Ukraine (1992–2012). Legend: Abscissa = Time (year); 
Ordinate = relative percentage of the bacterial meningitis etiology; oblique lines = Meningococcal Infection (MI); 
vertical lines = Staphylococcal and Other PBM (caused by Staphylococcus aureus, Streptococcus groups A and B, Klebsiella 
pneumoniae, Escherichia coli, Listeria monocytogenes and other PBM); horizontal lines  = PBM of unknown etiology); points 
= PBM pneumococcus (Purulent Bacterial Meningitis caused by Streptococcus pneumoniae); black = Haemophilus influenzae 
type b (Hib-PBM).
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the incidence of MI decreased by 5.4 times. In 2012 in Ukraine, IMD incidence (0.75 per 
100,000) was comparable to the one of EU (0.7 per 100,000). However, death rate in Ukraine 
(0.09 per 100,000) was higher than in the EU (0.06 per 100,000). Also, this has to take into 
account that half of the cases of MI in Ukraine are not bacteriologically confirmed.
3.3. Seasonality of meningococcal infection in Ukraine
From 1992 to 2015, most IMD cases occurred in winter and spring, as for other respiratory 
diseases in Ukraine. IMD incidence peaked up in March, while the lowest number of cases 
was reported in August (Figure 4). During that same period of time, 938 cases of IMD were 
regularly reported on the monthly base, and seasonal increase was registered when the num-
ber of monthly cases exceeded 78 (938 cases / 12 month  = 78.2 ≈ 78). Seasonal incidence rise 
was lasted for 6 months (from December to June) with a cumulative total number of 554 cases 
corresponding 59.06% annual incidence (i.e., seasonal coefficient with regard to the 9.84% 
average for each of these months. A 334 (40.94%) as of MI cases occurred during the seasonal 
rise with a monthly increase of 6.82%. One can ultimately evaluate the cases associated with 
seasonal risk factors that were in 18.66%, i.e. (9.84% – 6.82%) × 6 months = 18.66%.
Thus, the impact of seasonal factors on the annual incidence is very moderate, that is, annual 
incidence of MI is due to the seasonality of not more than one-fifth of part. Over 80% of 
Figure 3. Morbidity and mortality dynamics of meningococcal infection in Ukraine of a decade of observation 
(1973–2015). Legend: Abscissa = time (year); Ordinate = patient meningococcal infection per 100,000 people; line with 
empty square  = Meningococcal Infection (total MI, all clinic forms); line with empty diamond = Invasive Meningococcal 
Disease (IMD); line with empty triangle = total Mortality of Meningococcal Infection.
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 incidence of MI depends on the action of permanent factors. Our hypothesis is that the pro-
portion of susceptible population and the frequency of contacts between people (at risk of 
infection) are the basic are a permanent risk of MI transmission. We also assume that its values 
are slightly slowly changing throughout the year. Such seasonal rise was observed in Europe 
from December to June is also characterized by a seasonality pattern as it is in Ukraine, with 
the highest rate reporting during winter [8].
3.4. Geographical distribution
The incidence of MI is unevenly distributed on a geographical ground and expressed by 
ANOVA MI incidence for the 1992–2013 period of times among administrative units of 
Ukraine. Estimated value (Fisher’s test = 8.52, > critical value of 1.52) rejects the null hypoth-
esis of no effect of geographical factors on the incidence of MI. Indeed, Figure 5 shows the 
uneven geographical distribution of the disease by administrative units with low, medium, 
and high levels of incidence.
At first, the geographical distribution of MI incidence depends on population age pyramid 
including, the total population of the study area, the urban population and the child popu-
lation of 0–14 or 0–4-year old. We therefore calculated the corresponding correlation coeffi-
cients, but ultimately lacked of statistical significance between prevalence and administrative 
units. MI incidence correlation coefficients, when compared to different group, were equal to: 
0.3260 versus population density; 0.036 versus total population; 0.1711 versus urban pop-
ulation percentage; 0.1370 versus children aged 0–14; and 0.1968 versus the children aged 
Figure 4. Seasonal distribution of meningococcal infection in Ukraine (1992–2015). Legend: Abscissa = time (months); 
Ordinate = absolute number of cases of meningococcal infection; Gray line = the average monthly number of Meningococcal 
Infection (MI) cases of long-term; Empty diamond = number of Meningococcal Infection (MI) cases by month.
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0–4 years. We believe that the lack of statistical significance between these indicators suggest 
sporadic (or random) spatial nature distribution of the disease. Also, ANOVA analysis shows 
significant differences in the incidence among oblasts, but the correlation analysis of indi-
vidual factors (population density, age structure, etc.) by oblasts did not show any incidence 
because the population density and age structure are indirect factors. Thus, we can assume 
that geographical factors of each individual territory are quite stable, while geography has 
a limited effect on changes in incidence of MI in Ukraine. Geographical distribution of MI 
incidence is useful for comparing performance in different areas, but it cannot account for 
observed differences more likely linked to the multicomponent result with other causal fac-
tors. Also, the variable power of causal factors in any oblast could explain the differences in 
the incidence oblasts. In our case, the geographical distribution of the incidence of MI is a little 
informative because do not allowed to identify direct factors (i.e., risk of infection and/or risk 
of susceptibility).
3.5. Age distribution
The total incidence of MI decreased over the study period in Ukraine among all age groups, 
while it remains the highest among young children (Figure 6).
In Ukraine, the proportion of MI infected children under 14 years represented 77.17% of 
all cases as compared to 49.81% among the same xc of age of other European countries at 
Figure 5. Incidence of meningococcal disease in Ukraine by oblast (1992–2013). Legend: light-gray = Low incidence of 
Meningococcal Disease (less than 25 percentiles, IR<1.69); moderately gray = Middle incidence of Meningococcal Disease 
(between 25 and 75 percentile, IR = 1.69 ÷ 2.18); gray = High incidence of Meningococcal Disease (higher 75 percentile, 
IR > 2.18).
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large [8]. Thus, children under 14 years in Ukraine are at a major risk for MI infection, and 
mortality rates account for 78.35% (Figure 7). Altogether, there is a strong direct relationship 
of MI incidence among age groups that exactly fit the local pyramid of age.
Figure 6. Dynamics of the incidence of meningococcal infection in Ukraine by age group (1990–2014). Legend: 
Abscissa = time (year); Ordinate = person with meningococcal infection per 100,000 people by age group; 
Triangle = Incidence of Meningococcal Disease among the population aged over 15 years; Square = Incidence of 
Meningococcal Disease among children aged 0-14 years; Diamond = Incidence of Meningococcal Disease among 
the total population.
Figure 7. Mortality of meningococcal infectious disease among you children by class of age (Ukraine, 1965–2012). 
Legend: Legend: Abscissa = time (year); Ordinate = person with meningococcal infection per 100,000 people by age 
class; Empty circle = Incidence of Meningococcal Disease among children aged 0-14 years; Square = Incidence of 
Meningococcal Disease among children aged 0-1 years; Diamond = Incidence of Meningococcal Disease among the total 
population; Triangle = Incidence of Meningococcal Disease among children aged 0-4 years.
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The correlation coefficient between the total number of cases of MI and the number of popula-
tion for the years was r = 0.9676 (1990–2014). The correlation coefficient between the overall 
incidence and the total population was r = 0.9556 (Figure 8).
The correlation coefficient between number of the MI cases among children 0–14 years of 
age and number of children was of 0.9531. The correlation coefficient between the MI inci-
dence among children 0–14 years of age and number of children was of 0.8163. The correla-
tion coefficient between the total incidence of MI and the number of children was 0.9239. 
The correlation coefficient between the total number of cases of MI and the number of chil-
dren was 0.9420.
All of the above present a direct and strong statistical correlation between the dynamics of age 
structure, the population and the incidence of MI. Peak incidence and mortality of meningo-
coccal disease occurred in Ukraine in the mid-80s, also corresponding to this time of national 
birth rates or a “baby boom.”
Children's age is an indirect risk factor for invasive meningococci disease (IMD), while young-
est children are more susceptibility to the pathogen, including predisposing factor of IMD 
and high transmission risk among over-crowded communities (i.e., school, recreation area, 
etc.). Incidence may also be reduced when the relative number of children decreases, and the 
whole population is aging (as it is in Ukraine and Europe). Indeed, during the study period, 
the number of children relatively decreased by twofold among general population, while the 
total number of population also decreased in Ukraine. Thus, we believe that the incidence 
of IMD in different age groups defined different levels of susceptibility of the pathogen for 
these groups.
Figure 8. The dynamics of relationship between the overall incidence of meningococcal infection and the general 
population (Ukraine, 1990–2014). Legend: Abscissa = time (year); Ordinate = case of meningococcal infection per 100,000 
people; Diamond = number of the total population; Triangle = Incidence of Meningococcal Disease among the total 
population.
Meningoencephalitis - Disease Which Requires Optimal Approach in Emergency Manner14
3.6. Spatial rural as compared to urban distribution of meningococcal infection
In Figure 9, we see that the frequency of MI between cities and villages differ slightly. 
In  cities, the total number and density of the population is greater than in the villages. This is 
evidenced by the result of ANOVA analysis of MI incidence for the period of 1990–2014 years 
for the urban and rural population of Ukraine. Estimated value of Fisher criterion (1.2) is less 
than the critical value (4.04). Thus, we have confirmed the statistical null hypothesis of no 
effect of residence on the incidence of MI.
These data may indicate that the percentage of the susceptible population in cities and towns 
are approximately equal. He also points to the sporadic incidence of MI in Ukraine.
3.7. Meningococcal carriage
Indeed, as a first factor in favor of such observations, one has to consider that meningococ-
cus carriage is the most widespread form of meningococcal infection, that is, for one patient 
with IMD there is an estimate of more than thousands asymptomatic carriers of the pathogen. 
Carriage rates can range between 1 and 50% while varies with age, socioeconomic status, and 
connected with the predominant strain circulating in the area, and a number that appears 
not to vary with season or herd immunity. However, nasopharyngeal carriage surveillance 
is not recommended neither reported as a practical useful public health tool [9]. Also, data 
on  nasopharyngeal carriage are available from state bacteriological laboratory in Ukraine 
(Ukrainian Centre for Disease Control and monitoring of the Ministry of Health of Ukraine) 
(Figure 10). Indeed, diagnostic tests are run annually by the Sanitary-epidemiological service 
Figure 9. Dynamics of meningococcal infection in Ukraine in rural and urban areas (1990–2014). Legend: Abscissa = time 
(year); Ordinate = case of meningococcal infection per 100,000 people; Circle = Incidence of Meningococcal Disease in 
urban settings; Square = Incidence of Meningococcal Disease in rural; Triangle = Incidence of Meningococcal Disease 
among total population.
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of Ukraine using nasopharyngeal swab. This approach was conducted in order to identify the 
level of circulating N. meningitidis in Ukraine among the healthy children and adolescents and 
also among all persons who had contact with MI patients, while contact persons represent all 
age groups or the general population. Such study was carried out in all 26 regions (oblasts) 
of Ukraine.
From 1992 to 2012, 890,061 people (average of 42,384/year) were investigated, moreover, 
482,435 healthy people (average of 23,973/year) of all ages who have had contact with con-
firmed patients with MI, were also tested for meningococcal carriage in Ukraine. The results 
of these time series of MI carriers are shown in Figure 9 and show the risk among healthy chil-
dren and adolescents as an average of 0.99% as compared to 1.97% of the general population. 
Ultimately, such risk of infection is a factor of emergence of IMD and determines the level of 
prevalence of a small percentage of carriers is due to the large stratum of old adults and the 
low sensitivity of bacterial tests in Ukraine. The risk of infection is a necessary susceptibility 
factor for the emergence of IMI and therefore constantly determines the level of prevalence of 
meningococcal carriage.
3.8. Meningococcus serogroup distribution
In 1992–2012, information on the meningococcus serogroups was reported for 9484 IMD cases 
in Ukraine. The meningococcus B serogroup was responsible for 48.9% of IMD, followed by 
the meningococcus A serogroup (15.78%) and the meningococcus C serogroup (13.21%). The 
meningococcus D, X, Y, Z, 29E and W135 made up to 3.19% of IMD cases. Non-capsular 
strains represented 18.91%. During that same period, total information on serogroup was 
reported for 15,868 carriers. The meningococcus serogroup B was responsible for 36.15% 
Figure 10. Meningococcal carriage dynamics among different population group survey in Ukraine (1992–2012). Legend: 
Abscissa = time (year); Ordinate = absolute number of carriers of meningococci; Circle = Prevalence (%) of meningococcal 
carriage among the healthy children and adolescents; Diamond  = Prevalence (%) of meningococcal carriage among 
persons who had contact with MI patients (all age groups or the general population).
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of carriers of meningococcal infections, followed by serogroup C (7.74%) and serogroup A 
(7.17%). The meningococcus serogroups D, X, Y, Z, 29E and W135 represented 6.75% of carri-
ers’ meningococcal infections the known serogroup. Not typed strain represented 42.19% of 
carriers of meningococcal infections (Figure 11).
In 2012, information on serogroup was reported for 3234 of confirmed IMD cases in EU coun-
tries including 68% of serogroup B, 17% of serogroup C (17%), and a total of 93% included 
B and C, Y [8]. It is clearly seen that in the EU and also in Ukraine IM case are due mostly to 
serogroup B, while serogroups B and C are less represented in Ukraine than in EU.
In 2008, serogroup C incidence of was 0.21 per 100,000 in Ukraine. In 2012, it dropped to 0.08 
per 100,000. From 2008 to 2012, this index was slightly higher than the 0.1 per 100,000 in EU/
EEA countries [9]. Thus, in the Ukraine, currently, the incidence of serogroup C is not differ-
ent for EU/EEA but in Ukraine not carried out vaccination against Men C. This fact does not 
negate the benefits of vaccination but requires further detailed study. When one compares the 
incidence Men type C in EU with routine vaccination and Ukraine, where routine vaccination 
against MI has never been carried out, the effectiveness of Men C vaccination appears negli-
gible because the incidence Men type C in EU and Ukraine is not different.
In Europe and Ukraine, decline in the incidence of other serogroups (A and B) was not the 
result of specific interventions. We believe that demographic situation in Ukraine population 
has decreased from 52 to 45 million over the past 25 years. Birth rate decreases, and therefore, 
child population falls, altogether this will certainly not contribute to an increase incidence 
of IMD in Ukraine for the coming decade. The introduction of routine vaccination of IMD in 
Ukraine requires careful study because there is limited funding for public health.
Figure 11. Distribution of meningococcus serogroups among patients with meningococcal disease (n = 9484) and 
healthy carriers of (n = 15,868), Ukraine, 1992–2012. Legend: Abscissa = Meningococcus serogroups; Ordinate = cases 
of meningococcal disease (%); red bar = healthy carriers of MI-pathogen (%); blue bar = patients with meningococcal 
disease (%).
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4. Clinics
Among the 18,914 cases of IMD reported in Ukraine, 38.4% were meningococcemia, 29.9% 
were meningococcemia with meningitis, 27.9% meningitis and others 2.8% were of different 
minor etiologies. Other clinical forms have not been also clearly recognized and characterized 
as pneumonia or mixed clinical forms.
Also, the distribution of clinical forms of IMD in Ukraine is very different from the one observed 
in the EU countries in which meningitis prevails for 43.0%. Meningococcemia and meningo-
coccemia with meningitis represent, respectively, 21.0 and 29.0% of total IMD in the EU [10].
Case fatality rate (CFR) of Meningococcal disease in Ukraine for the period considered 
(1992–2012) was of: 12.1% for IMD (n = 18,914); 18.9% for Meningococcemia (n = 7448); 10.1% 
for Meningococcemia (n = 5660); 5.94% of Meningitis (n = 5273); and 5.6% for others undefined 
clinical forms (n = 538).
In 2012, overall CFR in EU/EEA countries was 7.9%, (3185 confirmed IMD cases). The high-
est CFR reported (n = 1563) among cases presenting septicemia was 18.8%, followed by 
cases meningitis with septicemia of 11.1%, and then by cases with meningitis (3.7%) [11]. 
In Ukraine, the higher observed overall CFR of IMD greater than in the EU can be attributed 
to the frequency of septicemia.
Meningococcal disease CFR among children in Ukraine during the period of 2010–2015 ranged 
from 14.7 to 19.1% occurring as follows with respect to the age class: first year of life, 66%; 1–3-
year old, 30%; over three-year old, 4%. Among 77% of patient death occurred during the first 24 
h after onset.
According to the children’s infectious hospital of Kiev, for the past 15 years, serotypes prevail 
as follows: meningococcal serogroup B, 57%; serogroup A, 19%; serogroup C, 20%; and other 
serogroup, 4%. Meningococcemia was diagnosed in 47% of patient with meningococcemia, 
41% meningitis, while 12–76% of children with meningococcal disease had a complicated 
course of the disease, including septic shock, brain edema, multiple organ failure, dissemi-
nated intravascular coagulation syndrome, among others.
5. Multiple linear regression model
From this data set and temporal series, some tentative models were developed for a better 
understanding to the disease dynamics. Assuming that the proportion of susceptible indi-
viduals is a constant value a reported to a large population (eventually of genetic origin), this 
could explain the main feature of the epidemic process of meningococcal disease and ecologi-
cal characteristics of meningococcus commensality.
Also, meningococcus as a species may exist as a non-pathogenic microorganism. IMD will 
then arise only among susceptible people who have a genetic predisposition while in any 
large population, such a percentage is very small (<1%).
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In order to calculate the percentage of susceptible population to IMD, it is possible to cal-
culate it as a risk of susceptibility (RS), the percentage of susceptible, i.e. approximate pro-
portion of the population susceptible” (APPS) to IMD. In order to calculate APPS, we first 
calculate the annual estimated number of carriers, AAQC (infected people without clinical 
manifestations):
  APPS  =  (IMD number : AAQC )   ×  100% (1)
where AAQC = annual approximate quantity of carriers (infected people without clinical 
manifestations); CPR = carrier prevalence rate (from the ratio of the carriers detected among 
people examinees); N = the census of the population of the studied territory; 365 = days 
(i.e., a year); D = average duration of carriage status (not detected after 14 days).
where AAQC formula is derived f rom PR formula:
  AAQC =  CPR × N × 365  ___________D (2)
where PR = prevalence rate; IR = incidence rate; D = average day duration for one case of 
 carriage [12].
Ultimately, AAQC formula allows to convert the data of sample surveys (i.e., prevalence 
of meningococcal carriage showed (Figure 9) to indicators of incidence (or the annual 
approximate number of carriers). Thus, we calculated the AAQC among healthy children 
for the period 1992–2012 years. The AAQC of children was calculated from 2,206,475 per-
sons. The proportion of IMD cases (i.e., % susceptible) presented an average of 0.0360% 
± 0.0189, that is: in overall, one IMD patient associated with 5271 carriers in during 
1990–2012.
Moreover, this way we calculated indicators for period of time from 1992 to 2012 for the gen-
eral population. The annual average number of carriers in the general healthy population was 
24,990,502 persons (variation of 15,480,263–34,746,741 per year). The proportion of IMD cases 
(i.e., % susceptible) had an average of 0.0036% (0.0022–0.0058% per year), that is: one IMB 
patient associated an average of 29,729 carriers.
In overall, this is consistent with the fact that the IMD incidence among children exceeds IMD 
incidence in the general population (or adult) by 10-fold or more.
The total risk of disease (RD) is expressed as a product of risk of infection (RI) to risk of sus-
ceptibility (RS) where RD = RI × RS. Thus, in our paradigm, RS and RI are the final and neces-
sary causes of IMD emergence and spread to human population. All other causes that may 
affect IMD incidence will act indirectly through RI and RS.
Therefore, we built multiple regression models of the epidemic process of MI, where the inci-
dence of IMD is the dependent variable, while independent variables are the level of menin-
gococcal carriage (RI) and the proportion of the susceptible population (RS). The construct 
of the regression model was by deriving multiple regression method [12]. Multiple linear 
regression models of IMD in Ukraine were therefore developed [13]. We used for the model 
the data presented in the figures 6 and 10.
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Our first model takes the following form of the regression equation:
  Y1 = − 7.43 + 8.26  X 
1
 + 227.63  X 
2
 , (3)
where Y1 = IMD incidence per 100,000 children 0–14 years; −7.43 (or “a”) = constant, which 
corresponds to the mathematical expectation Х
1
 and Х
2
 if Y = 0; Х
1
 = prevalence of carriage 
among healthy children aged 0–14 (%); Х
2
 = approximate proportion of the population sus-
ceptible to the IMD among children aged 0–14, or APPS (%); 8.26 (or “b
1
”) = regression coef-
ficient showing the change of level Y, if Х
1
 is changed to 1%; 227.63 (or “b
2
”) = regression 
coefficient showing the change of level Y, if Х
2
 is changed to 1%.
Note that the influence of the regression coefficients (b
1
 and b
2
) and constant “a” at incidence 
Y is statistically significant (Student exact test: b
1
 = 14.56 with p = 2.13 × 10−11; b
2
 = 15.39 with 
p = 8.38 × 10−12; a = 7.54 with p = 5.59 × 10−7).
In the model, the coefficient of multiple correlation R = 0.9697 and its standard error is equal 
to 0.5069 (R2 = 0.9404, i.e. 94.04%) that statistically significance explains IMD incidence and 
shows the high descriptive properties of the model. Ultimately, this model appears highly 
significant (Fisher’s exact test = 142.04 p < 0.05 at 95% confidence) describing the totality of the 
properties of the epidemic process of MD among children aged 0–14. Analysis of the residu-
als values of the model did not find any autocorrelation. Overall, the model encompasses all 
properties and is statistically significant.
Our second model takes the following form of the regression equation:
  Y2 = − 1.59  +  0.89  X 
1
 + 469.13  X 
2
 , (4)
where Y2 = IMD incidence per 100,000 population; Х
1
 = prevalence of carriage among per-
sons who had contact with IMD patients (or among total population), %; Х
2
 = approximate 
proportion of the population susceptible to the IMD among total population, APPSIMD, %. 
The model has excellent descriptive properties and statistically significant. The coefficient of 
multiple correlation r = 0.9937 and its standard error is equal to 0.0645, accordingly with r2 = 
0.9875. Residuals analysis of the model did not find any autocorrelation (i.e., almost normal 
distribution.)
Model limitation: Our models use aggregated data form a survey, and therefore, our model 
does not allow for an adequate formal residual analysis. In order to perform such type of 
analysis, it requires to build at least 50 times of such models from necessary data sets. Also, 
our models do not take into account the potential heterogeneity of the pathogen.
6. Conclusion
Altogether the present and past surveillance of bacterial meningitis in Ukraine provide a 
unique source for a comprehensive understanding of the disease dynamics and, most impor-
tantly, allow to develop tools and strategies for control and prevention.
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Thus, the results of mathematical modeling of IMD using the available time series of data 
suggest that the nature of the main manifestations of the epidemic caused by the MI pro-
cess demonstrates the prevalence of meningococcal carriage and provides a measure of the 
of susceptible populations, which are both factors strongly associated and allow the assess-
ment of immediate risk of IMD in country. The proposed multiple linear regression model of 
epidemic process of meningococcal disease will improve epidemiological surveillance of the 
disease. Moreover, such models will provide a strong mean for assessing the quality of vac-
cination against invasive bacterial infections as well as diphtheria.
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